Schedule V controlled substances
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance category
|
| gptkbp:abuseMayLeadTo |
limited physical dependence
limited psychological dependence |
| gptkbp:acceptedMedicalUse |
true
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:definedIn |
gptkb:Controlled_Substances_Act
|
| gptkbp:example |
gptkb:Lomotil
gptkb:Motofen gptkb:Parepectolin gptkb:Lyrica cough preparations with less than 200 mg codeine per 100 ml |
| gptkbp:haveLowPotentialForAbuse |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V controlled substances
|
| gptkbp:legalStatus |
prescription required in most states
|
| gptkbp:lowerAbusePotentialThan |
gptkb:Schedule_IV_controlled_substances
|
| gptkbp:regulates |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:scheduleNumber |
5
|
| gptkbp:bfsParent |
gptkb:Section_829_(Prescriptions)
gptkb:Section_841_(Prohibited_acts_A) |
| gptkbp:bfsLayer |
6
|